Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker.

Darawan Rinchai Basirudeen Syed Ahamed Kabeer

Published in: F1000Research (2024)

Targeted assays measuring CEACAM6 transcript abundance in blood may be of potential utility for the management of patients with diseases presenting with systemic inflammation and for the management of patients with cancer, where the assay could potentially be run both on blood and tumor tissues.

Keyphrases

gene expression
high throughput
transcription factor
cancer therapy
case report
antibiotic resistance genes